Site notifications

Sub menu

 

 

Therapeutic goods advertising compliance: 2022-23 Annual Report

Published

This report covers the 2022-23 financial year. It is our fifth annual report on advertising compliance. Reporting on our enforcement and educational activities fosters transparency and accountability.

  • Executive summary    
  • 2022-23 Highlights    
  • About the advertising framework    
  • Advertising compliance data and information    
  • Unapproved therapeutic goods associated with COVID-19    
  • Unlawful import, advertising and supply of nicotine vaping products    
  • Compliance across the medicinal cannabis industry    
  • Unapproved performance and image enhancing products and sport supplements    
  • Advertising of therapeutic goods used in the cosmetic and beauty industry    
  • Advertising of unapproved goods on digital platforms    
  • Individual high-risk cases    
  • Compliance education    
  • Restricted and prohibited representations    
  • Version history    

Print version

Topics